31 results on '"Rohatgi, Anand"'
Search Results
2. The Relationship of Body Mass and Fat Distribution With Incident Hypertension: Observations From the Dallas Heart Study
3. Lifetime Risks for Cardiovascular Disease Mortality by Cardiorespiratory Fitness Levels Measured at Ages 45, 55, and 65 Years in Men: The Cooper Center Longitudinal Study
4. USING READILY AVAILABLE CLINICAL INFORMATION TO IDENTIFY INDIVIDUALS WITH HIGH LIPOPROTEIN A LEVELS: THE DALLAS HEART STUDY
5. Lipoprotein(a) and Family History Predict Cardiovascular Disease Risk
6. SOLUBLE FMS-LIKE TYROSINE KINASE-1 (SFLT-1) IS ASSOCIATED WITH SUBCLINICAL AND CLINICAL ASCVD: THE DALLAS HEART STUDY
7. INFLAMMATORY MARKER, GLYCA, OUTPERFORMS HSCRP IN PREDICTING CARDIOVASCULAR EVENTS
8. INFLUENCE OF POST-IMPLANTATION NON-FATAL ADVERSE EVENTS ON CONDITIONAL SURVIVAL IN PATIENTS WITH DURABLE LEFT VENTRICULAR ASSIST DEVICE SUPPORT FOR DESTINATION THERAPY
9. Impaired Renal Function on Cholesterol Efflux Capacity, HDL Particle Number, and Cardiovascular Events
10. NOVEL BIOMARKERS OF CORONARY ARTERY CALCIUM INCIDENCE OR PROGRESSION: INSIGHTS FROM THE DALLAS HEART STUDY
11. Is RCT (Reverse Cholesterol Transport) Ready for an RCT (Randomized Controlled Trial)?
12. LIPOPROTEIN(A) AND FAMILY HISTORY OF MYOCARDIAL INFARCTION: INSIGHTS FROM THE DALLAS HEART STUDY
13. RACIAL AND ETHNIC DIFFERENCES IN CARDIOVASCULAR BIOMARKERS
14. Beyond Coronary Calcification, Family History, and C-Reactive Protein
15. Association Between Peptidoglycan Recognition Protein-1 and Incident Atherosclerotic Cardiovascular Disease Events
16. LONG-TERM ASSOCIATION OF LDL CHOLESTEROL WITH CARDIOVASCULAR MORTALITY IN INDIVIDUALS AT LOW 10-YEAR RISK OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: THE COOPER CENTER LONGITUDINAL STUDY
17. ENDOTHELIAL CELL-SELECTIVE ADHESION MOLECULE AND INCIDENT CARDIOVASCULAR EVENTS IN THE DALLAS HEART STUDY
18. THE ASSOCIATION BETWEEN PEPTIDOGLYCAN RECOGNITION PROTEIN-1 AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE EVENTS IN THE DALLAS HEART STUDY
19. Cholesterol Efflux Capacity as a Therapeutic Target
20. Body Fat Distribution and Incident Cardiovascular Disease in Obese Adults
21. HIGH DENSITY LIPOPROTEIN CHOLESTEROL EFFLUX CAPACITY AS A NOVEL RISK MARKER FOR INCIDENT ATHEROSCLEROTIC CARDIOVASCULAR DISEASE INDEPENDENT OF FAMILY HISTORY OR PREVALENT CORONARY CALCIUM IN A MULTI-ETHNIC POPULATION-BASED STUDY
22. CORONARY CALCIUM AND FRAMINGHAM RISK SCORE TRAJECTORIES: INSIGHTS FROM THE DALLAS HEART STUDY
23. FAMILY HISTORY OF MYOCARDIAL INFARCTION IS INDEPENDENT AND ADDITIVE TO CORONARY CALCIUM: THE DALLAS HEART STUDY
24. THE RELATIONSHIP BETWEEN DEPRESSED LEFT VENTRICULAR FUNCTION BY CARDIAC MRI AND TRADITIONAL CARDIOVASCULAR RISK FACTORS IN PATIENTS EXPOSED TO ANTHRACYCLINES
25. ASSOCIATIONS OF VISCERAL AND SUBCUTANEOUS ADIPOSE TISSUE MASS WITH MARKERS OF CARDIOMETABOLIC RISK IN OBESE ADULTS: OBSERVATIONS FROM THE DALLAS HEART STUDY
26. THE ASSOCIATION BETWEEN 2011 ACCF/ASE/AHA/ASNC/HFSA/HRS/SCAI/SCCM/SCCT/SCMR APPROPRIATE USE CRITERIA FOR TRANSTHORACIC ECHOCARDIOGRAPHY AND CLINICAL IMPACT
27. INTERACTIONS BETWEEN SMOKING, CIRCULATING PULMONARY SURFACTANT PROTEIN-B AND AORTIC ATHEROSCLEROSIS IN THE DALLAS HEART STUDY
28. Assessing Clinical Utility of Carotid Intima-Media Thickness on the Basis of Reclassification
29. The Relationship of Body Mass and Fat Distribution With Incident Hypertension Observations From the Dallas Heart Study
30. Lifetime Risks for Cardiovascular Disease Mortality by Cardiorespiratory Fitness Levels Measured at Ages 45, 55, and 65 Years in Men The Cooper Center Longitudinal Study
31. Cholesterol Efflux Capacity as a Therapeutic Target Rationale and Clinical Implications∗
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.